Formula for treating hepatitis C

A formula, hepatitis C technology, applied in the direction of pharmaceutical formulas, medical preparations containing active ingredients, medical raw materials derived from fungi, etc., can solve the problem of uneven quality, wide difference in curative effect, body temperature, and heat that cannot be discharged from skin pores and other issues, to achieve rapid onset, scientific compatibility, and good curative effect

Inactive Publication Date: 2018-03-06
徐州万邦电子科技有限公司
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] When catching a cold, the body temperature often reaches above 38.5°. Generally, there are two states of sweating and fever, or no sweating and body heat. Most patients will take treatment for hepatitis C or hang water. It is a drug that dilates blood vessels on the body surface, increases heat dissipation through sweating and other processes, and at the same time inhibits shivering and reduces body heat production. Damage to kidney function, etc., especially when such drugs are used for a long time or overdose, the side effects will be more significant. Chinese medicine believes that cold and

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0007] A formula for treating hepatitis C. The raw materials in the formula are composed by weight percentage: 5% Xiangjunchen, 1% Bupleurum, 1% Astragalus, 5% Salvia, 3% Gentian, 2% Radix, and 1% Poria , Polyporus 11%, Dandelion 5%, Lycium barbarum 3%, Weeping grass 3%, Desmodium 1%, American ginseng 5%, Schisandra 1%, Ligustrum lucidum 4%, Shandou root 2%, Smilax 0.4% , 1% raw coix seed, 2% gentian grass, and 1% borneol. At this time, the treatment of hepatitis C has excellent thermal shock resistance, but the high temperature resistance is insufficient.

Embodiment 2

[0009] A prescription for treating hepatitis C. The raw materials in the recipe are composed by weight percentage: 15% fungi, 5% Bupleurum, 10% astragalus, 15% salvia, 9% gentian, 3% isatidis, 5% poria, Polyporus 19%, Dandelion 7%, Lycium barbarum 5%, Weeping grass 5%, Desmodium 5%, American ginseng 10%, Schisandra 1.5%, Ligustrum lucidum 5%, Shandou root 4%, Smilax 0.6%, Raw Yiren 2%, Gentiana 4%, and Borneol 3%, at this time, the treatment of hepatitis C has high temperature resistance but its thermal shock resistance is insufficient.

Embodiment 3

[0011] A formula for treating hepatitis C. The raw materials in the formula are composed by weight percentage: 10% fungi, 1.5% Bupleurum, 5% astragalus, 10% salvia, 3.9% gentian, 2.3% isatidis, 1.5% poria, Polyporus 14%, Dandelion 5.7%, Lycium barbarum 3.5%, Weeping grass 3.5%, Desmodium 1.5%, American ginseng 6%, Schisandra 1.12%, Ligustrum lucidum 4.5%, Shandou root 2.4%, Smilax 0.5%, Raw coix seed 1.2%, gentian grass 2.4%, borneol 1.3%, at this time, the treatment of hepatitis C has high thermal shock stability and high temperature resistance.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a formula for treating hepatitis C. The raw materials in the formula are composed of 5-15% mushroom, 1-5% Bupleurum, 1-10% astragalus, 5-15% salvia miltiorrhiza, and gentian 3‑9%, Radix Radix 2‑3%, Poria 1‑5%, Polyporus 11‑19%, Dandelion 5‑7%, Lycium barbarum 3‑5%, Weeping grass 3‑5%, Desmodium 1‑5 %, American Ginseng 5‑10%, Schisandra 1‑1.5%, Ligustrum lucidum 4‑5%, Bean Root 2‑4%, Smilax 0.4‑0.6%, Raw Coix Seed 1‑2%, Gentiana 2‑4 %, borneol 1-3%, the treatment of hepatitis C of the present invention has the effect of stably lowering blood pressure without rebounding, long-term stable blood pressure, no need for long-term medication, no drug resistance, safe and no side effects, suitable for a wide range of people, and is a caring medicine for ordinary people .

Description

technical field [0001] The invention relates to a formula for treating hepatitis C and belongs to the field of pharmacy. Background technique [0002] When catching a cold, the body temperature often reaches above 38.5°. Generally, there are two states of sweating and fever, or no sweating and body heat. Most patients will take treatment for hepatitis C or hang water. It is a drug that dilates blood vessels on the body surface, increases heat dissipation through sweating and other processes, and at the same time inhibits shivering and reduces body heat production. Damage to kidney function, etc., especially when such drugs are used for a long time or overdose, the side effects will be more significant. Chinese medicine believes that cold and fever are caused by the five internal organs regulating the five qi to generate physical energy and generate body temperature. If the five internal organs regulate the five qi, the heat cannot be discharged , because the pores of the sk...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/90A61K36/8994A61P1/16A61P31/14A61K31/045
CPCA61K36/90A61K31/045A61K36/07A61K36/076A61K36/185A61K36/195A61K36/233A61K36/258A61K36/282A61K36/288A61K36/315A61K36/41A61K36/481A61K36/489A61K36/515A61K36/53A61K36/537A61K36/57A61K36/638A61K36/79A61K36/815A61K36/896A61K36/8994A61K2300/00
Inventor 李怀贵
Owner 徐州万邦电子科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products